North America Prostate Cancer Diagnostics Market to 2032
Overview
The North America Prostate Cancer Diagnostics Market is expected to reach a 6.49 USD Billion by 2032 and is projected to grow at a CAGR of 16.84% from 2025 to 2032.
Revenue, 2024 (USD Billion)
2.45
Forecast, 2032 (USD Billion)
6.49
CAGR, 2024 - 2032
16.84%
Report Coverage
North America
North America Prostate Cancer Diagnostics Market 2018-2032 USD Billion
North America Prostate Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 2.45 USD Billion
- Projected Market Size (2032): 6.49 USD Billion
- CAGR (2025-2032): 16.84%
Key Findings of North America Prostate Cancer Diagnostics Market
- The North America Prostate Cancer Diagnostics Market was valued at 6.49 USD Billion in 2024.
- The North America Prostate Cancer Diagnostics Market is likely to grow at a CAGR of 16.84% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Pediatric in Age Group Segment accounted for the largest share of the market with a revenue of 2.45 USD Billion
- The fastest growing segment Localized Prostate Cancer in Stage Segment grew Fastest with a CAGR of 18.79% during the forecast period from 2024 to 2032.
North America Prostate Cancer Diagnostics Market Scope
North America Prostate Cancer Diagnostics Market Segmentation & Scope
End User
- Cancer Research Institutes
- Ambulatory Surgical Centers
- Clinics
- Hospitals
- Independent Diagnostic Laboratories
- Others
Distribution Channel
- Direct Tender
- Retail Sales
Age Group
- Adult
- Geriatrics
- Pediatric
Type
- Small Cell Carcinoma
- Prostatic Adenocarcinoma
- Others
Stage
- Castration-Resistant Prostate Cancer (Metastatic and Non-Metastatic)
- Localized Prostate Cancer
- Recurrent/Advanced Prostate Cancer
Sample Type
- Urine
- Tissue
- Blood
- Others
Diagnostics Type
- Confirmatory Tests
- Preliminary Screening Tests
Product Type
- Accessories
- Instruments
- Reagents & Consumables
North America Prostate Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 2.45 USD Billion |
| Market Value in 2032 | 6.49 USD Billion |
| CAGR (2025-2032) | 16.84% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Distribution Channel,Age Group,Type,Stage,Sample Type,Diagnostics Type,Product Type |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 2.45 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 2,200.92 USD Million in 2024.
Segments and Scope
-
North America Prostate Cancer Diagnostics Market to 2032, By End User
- Independent Diagnostic Laboratories is the largest segment in North America Prostate Cancer Diagnostics Market to 2032 with a revenue of 326.72 USD Billion in the year 2024.
- Independent Diagnostic Laboratories is the Fastest growing segment in North America Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 16.67 % in forecast period 2025-2032.
-
North America Prostate Cancer Diagnostics Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in North America Prostate Cancer Diagnostics Market to 2032 with a revenue of 423.70 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in North America Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 13.64 % in forecast period 2025-2032.
-
North America Prostate Cancer Diagnostics Market to 2032, By Age Group
- Pediatric is the largest segment in North America Prostate Cancer Diagnostics Market to 2032 with a revenue of 2.45 USD Billion in the year 2024.
- Pediatric is the Fastest growing segment in North America Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 16.84 % in forecast period 2025-2032.
-
North America Prostate Cancer Diagnostics Market to 2032, By Type
- Prostatic Adenocarcinoma is the largest segment in North America Prostate Cancer Diagnostics Market to 2032 with a revenue of 80.10 USD Billion in the year 2024.
- Prostatic Adenocarcinoma is the Fastest growing segment in North America Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 15.47 % in forecast period 2025-2032.
-
North America Prostate Cancer Diagnostics Market to 2032, By Stage
- Recurrent/Advanced Prostate Cancer is the largest segment in North America Prostate Cancer Diagnostics Market to 2032 with a revenue of 2.45 USD Billion in the year 2024.
- Localized Prostate Cancer is the Fastest growing segment in North America Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 16.84 % in forecast period 2025-2032.
-
North America Prostate Cancer Diagnostics Market to 2032, By Sample Type
- Blood is the largest segment in North America Prostate Cancer Diagnostics Market to 2032 with a revenue of 370.59 USD Billion in the year 2024.
- Blood is the Fastest growing segment in North America Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 15.78 % in forecast period 2025-2032.
-
North America Prostate Cancer Diagnostics Market to 2032, By Diagnostics Type
- Preliminary Screening Tests is the largest segment in North America Prostate Cancer Diagnostics Market to 2032 with a revenue of 1.91 USD Billion in the year 2024.
- Preliminary Screening Tests is the Fastest growing segment in North America Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 17.39 % in forecast period 2025-2032.
-
North America Prostate Cancer Diagnostics Market to 2032, By Product Type
- Reagents & Consumables is the largest segment in North America Prostate Cancer Diagnostics Market to 2032 with a revenue of 1.91 USD Billion in the year 2024.
- Reagents & Consumables is the Fastest growing segment in North America Prostate Cancer Diagnostics Market to 2032 with a Growth rate of 17.30 % in forecast period 2025-2032.
North America Prostate Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Myriad Genetics, Inc. | |||
| OPKO Health, Inc. | |||
| Beckman Coulter, Inc. | |||
| Abbott | |||
| F. Hoffmann-La Roche Ltd. | |||
North America Prostate Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion
North America Prostate Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The North America Prostate Cancer Diagnostics Market is segmented based on Segmentation End User,Distribution Channel,Age Group,Type,Stage,Sample Type,Diagnostics Type,Product Type.
North America Prostate Cancer Diagnostics Market was valued at USD 2.45(Revenue in USD Billion) in 2022.
North America Prostate Cancer Diagnostics Market is projected to grow at a CAGR of 16.84% during the forecast period of 2024 to 2032.
The Pediatric segment is expected to dominate the North America Prostate Cancer Diagnostics Market, holding a largest market share of 2.45 USD Billion in 2024
North America Prostate Cancer Diagnostics Market Scope
North America Prostate Cancer Diagnostics Market Segmentation & Scope
End User
- Cancer Research Institutes
- Ambulatory Surgical Centers
- Clinics
- Hospitals
- Independent Diagnostic Laboratories
- Others
Distribution Channel
- Direct Tender
- Retail Sales
Age Group
- Adult
- Geriatrics
- Pediatric
Type
- Small Cell Carcinoma
- Prostatic Adenocarcinoma
- Others
Stage
- Castration-Resistant Prostate Cancer (Metastatic and Non-Metastatic)
- Localized Prostate Cancer
- Recurrent/Advanced Prostate Cancer
Sample Type
- Urine
- Tissue
- Blood
- Others
Diagnostics Type
- Confirmatory Tests
- Preliminary Screening Tests
Product Type
- Accessories
- Instruments
- Reagents & Consumables
Frequently Asked Questions
The North America Prostate Cancer Diagnostics Market is segmented based on Segmentation End User,Distribution Channel,Age Group,Type,Stage,Sample Type,Diagnostics Type,Product Type.
North America Prostate Cancer Diagnostics Market was valued at USD 2.45(Revenue in USD Billion) in 2022.
North America Prostate Cancer Diagnostics Market is projected to grow at a CAGR of 16.84% during the forecast period of 2024 to 2032.
The estimated market value of the North America Prostate Cancer Diagnostics Market for final year is USD 6.49 (USD Billion).
North America Prostate Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The North America Prostate Cancer Diagnostics Market is segmented based on Segmentation End User,Distribution Channel,Age Group,Type,Stage,Sample Type,Diagnostics Type,Product Type.
North America Prostate Cancer Diagnostics Market was valued at USD 2.45(Revenue in USD Billion) in 2022.
North America Prostate Cancer Diagnostics Market is projected to grow at a CAGR of 16.84% during the forecast period of 2024 to 2032.
The estimated market value of the North America Prostate Cancer Diagnostics Market for final year is USD 6.49 (USD Billion).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.